Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
Dear Readers,Welcome to the latest issue of Microb
Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast.
The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion.
The vaccine was among the first to be authorized for emergency use in the USA and various other countries, and analysts have forecast billions in sales.
In the fourth quarter, the vaccine brought in sales of $154 million, below expectations of $462 million, according to consensus estimates compiled by brokerage Mizuho.
The company now expects full-year adjusted earnings of $3.10 to $3.20 per share, up from its prior forecast of $3 to $3.10 per share.